ReviewThe factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling
Graphical abstract
Introduction
Local vascular tone is determined by a variety of factors such as neuro-transmitters released from autonomic nerves, circulating vasoactive compounds, tissue metabolites and endothelium-derived autacoids. The best characterized vasodilator autacoids are nitric oxide (NO) and prostacyclin (PGI2), but a substantial component of the vasodilator response observed in response to receptor-dependent agonists or increases in flow is insensitive to inhibitors of NO synthases or cyclooxygenases (COXs). The existence of a NO/PGI2-independent component of endothelium-dependent relaxation is particularly prominent in the microcirculation as well as in coronary, mesenteric and renal arteries. Since the NO/PGI2-independent vasodilatation originally described was co-incident with vascular smooth muscle hyperpolarization, and was abolished by depolarizing concentrations of potassium, it was proposed to be mediated by an endothelium-derived hyperpolarizing factor or “EDHF” [1], [2].
As the name implies an endothelium-derived hyperpolarizing factor would be expected to be a substance generated in and released from endothelial cells that is able to stimulate the hyperpolarization of underlying vascular smooth muscle cells. Such a factor would not be expected to be generated in large amounts under resting conditions but its production should be stimulated by hemodynamic stimuli such as cyclic stretch, fluid shear stress and increases in pressure (myogenic response), as well as in response to classical vasodilating agonists. Characterizing the nature of the proposed factor was partially a case for “fridge pharmacology” i.e. the testing of a number of enzymatic inhibitors and ion channel blockers on agonist induced hyperpolarization responses. Relatively early on the field split into two camps: those studying arteries in which the EDHF response was blocked by iberiotoxin and implicating large conductance calcium activated potassium (BKCa) channels [3], [4], [5], and those studying arteries in which the response was abrogated by the combination of charybdotoxin and apamin implying small and intermediate conductance KCa (SKCa and IKCa) channels [6], [7], [8], [9]. While the former responses were largely also sensitive to substances such as the cytochrome P450 (CYP) inhibitors, clotrimazole, miconazole and 17-octadecynoic acid, arteries in which EDHF responses were linked to SKCa and IKCa channel activation were generally not. For quite a while the field failed to advance significantly with an “it is” versus “it is not” type of discussion dominating the literature. The realization that myo-endothelial gap junctional communication may also represent a means of transferring hyperpolarization between endothelial cells and smooth muscle cells without the need for a diffusible factor per se [10], [11], [12] prompted a review of the available evidence and the realization that at least three different mechanisms may underlie the agonist induced NO- and PGI2-independent hyperpolarization of smooth muscle cells from different vascular beds [13]. Thus, the original EDHF type responses can now be attributed to (i) the activation of endothelial cell SKCa and IKCa channel activation and the induction of K+ ion-induced vascular smooth muscle cell hyperpolarization, (ii) myo-endothelial gap junctional transfer, and (iii) the generation of CYP-derived products of arachidonic acid [14], [15]. There may also be an additional role for endothelial cell derived hydrogen peroxide [16], [17]. Which of these mechanisms dominates in which vascular bed is determined by a number of factors, including the architecture of the vasculature as well as by tissue specific differences in gene expression.
The fact that arachidonic acid was able to induce vascular smooth muscle cell hyperpolarization independent of an increase in cyclic nucleotides together with studies using pharmacological inhibitors of phospholipase A2 (PLA2) and CYP enzymes certainly suggested that CYP-derived metabolites of arachidonic acid may act as an EDHF [18], [19], [20]. Moreover, many CYP enzymes are sensitive to inhibition by high concentrations of NO, which fit with observations that EDHF-mediated hyperpolarization and vasodilatation was most prominent when NO production was inhibited [21]. Also, in bioassay systems it was possible to demonstrate the release of a physically transferable endothelium-derived CYP metabolite that could elicit smooth muscle cell hyperpolarization [3]. However, definitive demonstration of the importance of these enzymes came with the report that two epoxides of arachidonic acid i.e. 11,12- and 14,15-epoxyeicosatrienoic acid (EET) were able to elicit the activation of KCa channels in bovine coronary arteries to induce hyperpolarization and relaxation [5]. A short time later, it was possible to identify a CYP2C enzyme in porcine coronary artery endothelial cells and demonstrate that the downregulation of this enzyme attenuated agonist-induced hyperpolarization and relaxation [4], [22].
There is at least circumstantial evidence for a similar CYP-dependent vasodilator pathway in humans as inhibitors such as sulfaphenazole have been found to be both ineffective [23] as well as effective [24], [25], [26], [27] in modulating vasodilatation in healthy subjects. The reason for the discrepancy seems to be the vascular bed studied. For example, while CYP inhibitor-sensitive responses in the forearm vasculature in its entirety are difficult to demonstrate, more clear-cut data were obtained when skeletal muscle arterioles [24] and the radial artery [25], [26], [27] were studied; tissues in which it was possible to confirm the expression of CYP2C protein [24], [27].
How are EETs generated? Ca2 + elevating receptor dependent agonists have frequently been used to increase CYP activity and EET production with bradykinin has been particularly effective in the endothelium [4], [5]. Adenosine 2A receptors (A2AR) seemingly play an important role in the kidney, in particular during the development of salt sensitive hypertension [28]. Following an increase in cell Ca2 +, PLA2 is activated to liberate arachidonic acid from membrane phospholipids. The latter serves as a substrate for CYP enzymes and results in the generation of epoxides that can affect vascular tone. As metabolism of arachidonic acid seems to take place more or less immediately, it seems that the regulation of CYP activity is largely determined by substrate availability combined with the expression of the enzymes involved. Some of the CYP enzymes are known to be phosphorylated [29], [30] but to date there has been no indication that this plays a major role in the acute generation of vasodilator EETs.
As far as endothelial cells are concerned the vast majority of reports indicate that CYP-derived lipid mediators elicit vasodilation, however CYP enzymes in vascular smooth muscle cells also catalyze the generation of hydroxy metabolites such as 20-hydroxyeicosatetraenoic acid (20-HETE) that elicit vasoconstriction — at least in the systemic circulation. The situation is reversed in the pulmonary circulation in which 20-HETE can act as a vasodilator [31] and 11,12-EET as a vasoconstrictor [32], [33]. This review focuses on CYP-derived epoxides and the systemic endothelium, but for more detailed information on the role of CYP metabolites in vascular smooth muscle cells see two excellent recent reviews [34], [35].
Intracellular levels of the EET epoxides are tightly regulated and metabolism occurs relatively rapidly by hydrolysis, β-oxidation and chain elongation [36]. The soluble epoxide hydrolase (sEH) is the most important epoxide-metabolizing enzyme that generates dihydroxyeicosatrienoic acids (DHETs) that are generally less active than the parent epoxides (at least as far as eliciting vasodilatation is concerned). The development of sEH inhibitors and transgenic sEH mice — both of which increase tissue and circulating EET levels, has contributed immensely to the identification of the biological actions of the CYP epoxides and diols [37], [38].
While CYP activity is determined by expression and substrate availability, the activity of the sEH can be regulated by post-translational modification. For example, two tyrosine residues (Tyr383 and Tyr466) in the active site of the hydrolase that are reportedly essential for enzyme activity [39], where found to be nitrated by peroxynitrite in vitro and in vivo in mouse models of type 1 and type 2 diabetes, leading to a decrease in sEH activity [40]. The sEH was also recently reported to be nitrosated in leptin-stimulated wild-type but not endothelial NO synthase knockout mice, suggesting that the effects of NO on arachidonic acid metabolism may be partly related to the modulation of sEH activity [41]. The sEH can also be targeted by high concentrations of electrophilic oxidants such as 15-deoxy-Δ-prostaglandin J2, e.g. during inflammation, to attenuate sEH activity and increase EET levels [42].
Section snippets
Downstream mediators
The realization that EETs, especially 11,12- and 14,15-EET, can activate large conductance BKCa channels on vascular smooth muscle cells to elicit hyperpolarization and relaxation led to their identification as a class of EDHF [4], [5]. How EETs were able to access these channels was unclear and the mechanism was presumed to be indirect as the nature of the patch clamp studies used to detect channel activation meant that the channel itself was physically isolated from the EET-containing
Blood pressure and vascular reactivity
There are a number of mechanisms by which EETs can potentially affect blood pressure including direct effects on vascular tone and ascending dilation as well as the regulation of renal sodium excretion. Working out which CYP enzyme may play a crucial role in which process is complicated by the fact that there are major differences in the CYP isoforms expressed by mice and humans. To complicate matters further, the genetic deletion of one CYP isoform in mice frequently leads to the up- or
Expanding the concept: more than arachidonic acid
The CYP-dependent metabolism of arachidonic acid is often referred to as the third pathway for arachidonic acid metabolism i.e. in addition to the COX and lipoxygenase (LOX) pathways. This definition implies that the arachidonic acid-derived epoxides and diols are the dominant CYP derived products affecting physiology and pathophysiology, which is clearly not the case in all tissues. It cannot be stressed enough that the CYP epoxygenases are able to metabolize a wide range of endogenous PUFAs
Summary and outlook
It is clear that the research on the biological actions of PUFA epoxides and EDHF (or mechanisms of relaxation linked to hyperpolarization-induced relaxation) that began in parallel have now largely parted ways. It remains valid to classify the EETs as classical EDHFs but so many hyperpolarization-independent effects of the EETs and other PUFA metabolites have been identified in recent years that the use of the term EDHF only describes a small aspect of epoxide biology. Also, with increased
Sources of funding
Work performed in the author's own laboratory was supported by the Deutsche Forschungsgemeinschaft (SFB/TR-23 A6, SFB 1039/A6 and Exzellenzcluster 147 “Cardio-Pulmonary System”).
Disclosures
None.
Acknowledgements
The author acknowledges the work of the many groups whose work has not been cited here because of space limitations.
References (145)
- et al.
EDHF: bringing the concepts together
Trends Pharmacol Sci
(2002) - et al.
From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling
Pharmacol Ther
(2006) Role of the adenosine2A receptor-epoxyeicosatrienoic acid pathway in the development of salt-sensitive hypertension
Prostaglandins Other Lipid Mediat
(2012)- et al.
Proteolytic degradation of heme-modified hepatic cytochromes P450: a role for phosphorylation, ubiquitination, and the 26S proteasome?
Arch Biochem Biophys
(1999) Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function
Prostaglandins Other Lipid Mediat
(2013)- et al.
Arachidonic acid monooxygenase: genetic and biochemical approaches to physiological/pathophysiological relevance
Prostaglandins Other Lipid Mediat
(2015) - et al.
Soluble epoxide hydrolase: gene structure, expression and deletion
Gene
(2013) - et al.
Biochemical evidence for the involvement of tyrosine in epoxide activation during the catalytic cycle of epoxide hydrolase
J Biol Chem
(2000) - et al.
Inhibition of the soluble epoxide hydrolase by tyrosine nitration
J Biol Chem
(2009) - et al.
Activation of Gαs mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids
J Biol Chem
(2001)
Vascular pharmacology of epoxyeicosatrienoic acids
Adv Pharmacol
Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)
Prostaglandins Other Lipid Mediat
Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry
J Biol Chem
Arachidonic acid diols produced by cytochrome P-450 monooxygenases are incorporated into phospholipids of vascular endothelial cells
J Biol Chem
A novel pool of rat liver inositol and ethanolamine phospholipids contains epoxyeicosatrienoic acids (EETs)
Biochem Biophys Res Commun
Endogenous epoxyeicosatrienoyl-phospholipids. A novel class of cellular glycerolipids containing epoxidized arachidonate moieties
J Biol Chem
Differences in positional esterification of 14,15-epoxyeicosatrienoic acid in phosphatidylcholine of porcine coronary artery endothelial and smooth muscle cells
Prostaglandins Other Lipid Mediat
Expression of the cytochrome P450 epoxygenase CYP2J2 in human monocytic leukocytes
Life Sci
Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases
Lancet
CYP2S1: a short review
Toxicol Appl Pharmacol
Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels
Br J Pharmacol
Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide)
Naunyn Schmiedebergs Arch Pharmacol
A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells
J. Physiol. Lond.
Cytochrome P450 2C is an EDHF synthase in coronary arteries
Nature
Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors
Circ Res
Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery
Br J Pharmacol
Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig
Br J Pharmacol
Apamin-sensitive K+ channels mediate an endothelium-dependent hyperpolarization in rabbit mesenteric arteries
J Physiol
Human coronary arteriolar dilation to bradykinin depends on membrane hyperpolarization. Contribution of nitric oxide and Ca2 +-activated K+ channels
Circulation
Central role of heterocellular gap junctional communication in endothelium-dependent relaxations of rabbit arteries
J. Physiol. Lond.
Peptides homologous to the extracellular loop motifs of connexin 43 reversibly abolish rhythmic contractile activity in rabbit arteries
J. Physiol. Lond.
Inhibition of the gap junctional component of endothelium-dependent relaxations in rabbit iliac artery by 18-α glycyrrhetinic acid
Br J Pharmacol
EDHF: spreading the influence of the endothelium
Br J Pharmacol
Whatever happened to the epoxyeicosatrienoic acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasis
Antioxid Redox Signal
H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles
Circ Res
EDHF: an update
Clin Sci (Lond)
Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney
Br J Pharmacol
Role of K+ channels in the vasodilator response to bradykinin in the rat heart
Br J Pharmacol
Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation
Br J Pharmacol
Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor
Circulation
Antisense oligonucleotides against cytochrome P450 2C8 attenuate EDHF-mediated Ca2 + changes and dilation in isolated resistance arteries
FASEB J
Cytochrome P450 2C9 plays an important role in the regulation of exercise-induced skeletal muscle blood flow and oxygen uptake in humans
J. Physiol. Lond.
Crucial role of NO and endothelium-derived hyperpolarizing factor in human sustained conduit artery flow-mediated dilatation
Hypertension
Evidence for a basal release of a cytochrome-related endothelium-derived hyperpolarizing factor in the radial artery in humans
Am J Physiol Heart Circ Physiol
Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and in patients with chronic heart failure
Eur J Heart Fail
Dual targeting of cytochrome P4502B1 to endoplasmic reticulum and mitochondria involves a novel signal activation by cyclic AMP-dependent phosphorylation at Ser128
EMBO J
Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries
J Appl Physiol
Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling
Hypertension
Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response
FASEB J
Epoxides and soluble epoxide hydrolase in cardiovascular physiology
Physiol Rev
Cited by (38)
Hyperpolarization and the endothelium
2023, Current Opinion in PhysiologyOverarching therapeutic challenges and arachidonic acid metabolism as a novel target in glioblastoma
2021, New Targeting in the Reversal of Resistant GlioblastomasImproved quantification of lipid mediators in plasma and tissues by liquid chromatography tandem mass spectrometry demonstrates mouse strain specific differences
2020, Prostaglandins and Other Lipid MediatorsCitation Excerpt :Prostaglandin H2 can then be subsequently transformed through various enzymes into additional prostaglandins, thromboxanes, and prostacyclins [4]. Multiple cytochrome P450 enzymes transform omega-3 and omega-6 fatty acids into epoxide intermediates which can then be transformed into various bioactive lipids through reaction with epoxide hydrolase [5–7]. AA-synthesized lipid mediators include several pro-inflammatory leukotrienes (LTs) and hydroxyeicosatetraenoic acids (HETEs), formed through LOX (Fig. 1).
Antihypertensive effects of allicin on spontaneously hypertensive rats via vasorelaxation and hydrogen sulfide mechanisms
2020, Biomedicine and PharmacotherapyRole of cytochrome P450-derived, polyunsaturated fatty acid mediators in diabetes and the metabolic syndrome
2020, Prostaglandins and Other Lipid MediatorsHypotensive effect of Eugenia dysenterica leaf extract is primarily related to its vascular action: The possible underlying mechanisms
2020, Journal of EthnopharmacologyCitation Excerpt :Non-NO/PGI2-mediated endothelium-dependent hyperpolarization and relaxation have been ascribed to a putative endothelium-derived hyperpolarising factor (EDHF) (Triggle et al., 2012). While some mediators have been proposed to be diffusible EDHFs, such as K+, epoxyeicosatrienoic acids, and hydrogen peroxide, it is now clear that activation of endothelial K+ channels initiates hyperpolarization, which spreads to the smooth muscle cells through myoendothelial gap junctions (MEGJs), triggering vascular relaxation by reducing the probability of calcium channel opening (Griffith, 2004; Triggle et al., 2012; Garland and Dora, 2017; Fleming, 2016). The sensitivity of EDLE-induced hypotension to carbenoxolone, a blocker of gap junctions that attenuates the vascular hyperpolarization induced by acetylcholine (Rozental et al., 2001; Griffith, 2004; Mathewson and Dunn, 2014), suggests a role for MEGJs signalling in the vascular effect of EDLE.